Training in clinical pharmacology

Are MHC class II-restricted cytotoxic T lymphocytes important?

Immunology today·2014

IFN-beta modulates specific T cell responses in vitro but does not affect Experimental Autoimmune Encephalomyelitis in the SJL mouse.

Journal of neuroimmunology·2000

Minor myelin proteins can be major targets for peripheral blood T cells from both multiple sclerosis patients and healthy subjects.

Journal of neuroimmunology·1993

HLA class I and II molecules present influenza virus antigens with different kinetics.

European journal of immunology·1992

Subacute sclerosing panencephalitis in The Netherlands--1976-1990.

International journal of epidemiology·1992

Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients.

Journal of neuroimmunology·1991

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

An Individualized, Interdisciplinary Approach to the Perioperative Care of Patients on Buprenorphine.

Current pain and headache reports·2026

Encephalopathy following subcutaneous administration of Brixadi® extended-release buprenorphine.

Toxicology reports·2026

Systematic understanding of acute effects of dexmedetomidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation.

American journal of physiology. Regulatory, integrative and comparative physiology·2026

A Micellar Electrokinetic Chromatography Screening Tool for Antiepileptic Drugs.

Electrophoresis·2026

In vivo evaluation of the dual MOP/NOP agonist AT121: a potent analgesic that delays opioid tolerance and offers a superior withdrawal suppression profile to methadone.

Neuroscience·2026

Identification of a Benzenesulfonylpiperazine Derivative With In Vivo Efficacy Against Visceral Leishmaniasis.

Chemical biology & drug design·2026

Related Experiment Videos

Training in clinical pharmacology

Related Concept Videos

Are MHC class II-restricted cytotoxic T lymphocytes important?

IFN-beta modulates specific T cell responses in vitro but does not affect Experimental Autoimmune Encephalomyelitis in the SJL mouse.

Minor myelin proteins can be major targets for peripheral blood T cells from both multiple sclerosis patients and healthy subjects.

HLA class I and II molecules present influenza virus antigens with different kinetics.

Subacute sclerosing panencephalitis in The Netherlands--1976-1990.

Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

An Individualized, Interdisciplinary Approach to the Perioperative Care of Patients on Buprenorphine.

Encephalopathy following subcutaneous administration of Brixadi® extended-release buprenorphine.

Systematic understanding of acute effects of dexmedetomidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation.

A Micellar Electrokinetic Chromatography Screening Tool for Antiepileptic Drugs.

In vivo evaluation of the dual MOP/NOP agonist AT121: a potent analgesic that delays opioid tolerance and offers a superior withdrawal suppression profile to methadone.

Identification of a Benzenesulfonylpiperazine Derivative With In Vivo Efficacy Against Visceral Leishmaniasis.

Related Experiment Videos

Training in clinical pharmacology

Related Concept Videos

Related Articles